癌症杀手可能不再“沉默”。 - Suppr

Suppr

超能文献

Cancer killer may be "silent" no more.

作者信息

Twombly Renee

出版信息

J Natl Cancer Inst. 2007 Sep 19;99(18):1359-61. doi: 10.1093/jnci/djm163. Epub 2007 Sep 11.

DOI:10.1093/jnci/djm163

PMID:17848663

Abstract

摘要

相似文献

Cancer killer may be "silent" no more.

J Natl Cancer Inst. 2007 Sep 19;99(18):1359-61. doi: 10.1093/jnci/djm163. Epub 2007 Sep 11.

The medical-surgical nurse's guide to ovarian cancer: part I.

Medsurg Nurs. 2007 Aug;16(4):259-66; quiz 267.

The not-so-silent killer.

Minn Med. 2005 Feb;88(2):12.

The 2003 model of the clinical practice of emergency medicine: the 2005 update.

Ann Emerg Med. 2006 Dec;48(6):e1-17. doi: 10.1016/j.annemergmed.2006.06.033. Epub 2006 Oct 2.

Providing basic spiritual care for patients: should it be the exclusive domain of pastoral professionals?

Am Fam Physician. 2001 Jan 1;63(1):36, 38-40.

Women's awareness of ovarian cancer risks and symptoms.

Am J Nurs. 2009 Sep;109(9):36-45; quiz 46. doi: 10.1097/01.NAJ.0000360309.08701.73.

'It whispers, so listen'.

RN. 2007 Oct;70(10):28-32; quiz 33.

Gynecology in the generalist's office.

Ethn Dis. 2003 Summer;13(3 Suppl 3):S3-50-1.

Ovarian cancer surgical practice guidelines. Society of Surgical Oncology practice guidelines.

Oncology (Williston Park). 1997 Jun;11(6):896-900, 903-4.

Ovarian cancer symptom index: possibilities for earlier detection.

Cancer. 2007 Jan 15;109(2):167-9. doi: 10.1002/cncr.22414.

引用本文的文献

The double-edged sword of ovarian cancer information for women at increased risk who have previously taken part in screening.

Ecancermedicalscience. 2016 Jun 30;10:650. doi: 10.3332/ecancer.2016.650. eCollection 2016.

Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.

Cochrane Database Syst Rev. 2016 Jun 29;2016(6):CD011322. doi: 10.1002/14651858.CD011322.pub2.

Targeted gene silencing using a follicle-stimulating hormone peptide-conjugated nanoparticle system improves its specificity and efficacy in ovarian clear cell carcinoma in vitro.

J Ovarian Res. 2013 Nov 20;6(1):80. doi: 10.1186/1757-2215-6-80.

Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.

Cochrane Database Syst Rev. 2013 Jun 6;2013(6):CD009620. doi: 10.1002/14651858.CD009620.pub2.

Symptoms and risk factors of ovarian cancer: a survey in primary care.

ISRN Obstet Gynecol. 2012;2012:754197. doi: 10.5402/2012/754197. Epub 2012 Aug 23.

Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.

Pathol Oncol Res. 2012 Apr;18(2):135-48. doi: 10.1007/s12253-011-9482-8. Epub 2011 Dec 9.

Current and future applications of magnetic resonance imaging (MRI) to breast and ovarian cancer patient management.

P R Health Sci J. 2010 Sep;29(3):223-31.

Predictive value of symptoms for early detection of ovarian cancer.

J Natl Cancer Inst. 2010 Feb 24;102(4):222-9. doi: 10.1093/jnci/djp500. Epub 2010 Jan 28.

Ovarian cancer pathogenesis: a model in evolution.

J Oncol. 2010;2010:932371. doi: 10.1155/2010/932371. Epub 2009 Sep 6.

Epidemiological and genetic factors associated with ovarian cancer.

Cancer Nurs. 2009 Jul-Aug;32(4):281-8; quiz 289-90. doi: 10.1097/NCC.0b013e31819d30d6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验